Abstract:Dan He, 1, &ast Qiao Yu, 2, &ast Xiaona Zeng, 2, &ast Jihua Feng, 2 Ruiqi Yang, 2 Huan Wan, 2 Ying Zhong, 2 Yanli Yang, 2 Ruzhi Zhao, 2 Junyu Lu, 3, 4 Jianfeng Zhang 1, 2, 4 1 Department of General Practice, The Second Affiliated Hospital of Guangxi Medical University, Nanning, 530007, People's Republic of China; 2 Department of Emergency Medicine, The Second Affiliated Hospital of Guangxi Medical University, Nanning, 530007, People's Republic of China; 3 Intensive Care Unit, The Second Affiliated Hospital of Guangxi Medical University, Nanning, 530007, People's Republic of China; 4 Guangxi Health Commission Key Laboratory of Emergency and Critical Medicine, Nanning, 530007, People's Republic of China &astThese authors contributed equally to this work Correspondence: Jianfeng Zhang, Junyu Lu, The Second Affiliated Hospital of Guangxi Medical University, No. 166 Daxuedong Road, Nanning, Guangxi, 530007, People's Republic of China, Tel +86 7713277166, Fax +86 7713277285, Email ; Background: Acute respiratory distress syndrome (ARDS) is caused by severe pulmonary inflammation and the leading cause of death in the intensive care unit. Methods: We used single-cell RNA sequencing to compare peripheral blood mononuclear cells from sepsis-induced ARDS (SEP-ARDS) and pneumonic ARDS (PNE-ARDS) patient. Then, we used the GSE152978 and GSE152979 datasets to identify molecular dysregulation mechanisms at the transcriptional level in ARDS. Results: Markedly increased CD14 cells were the predominant immune cell type observed in SEP-ARDS and PNE-ARDS patients. Cytotoxic cells and natural killer (NK) T cells were exclusively identified in patients with PNE-ARDS. An enrichment analysis of differentially expressed genes (DEGs) suggested that Th1 cell differentiation and Th2 cell differentiation were enriched in cytotoxic cells, and that the IL-17 signaling pathway, NOD receptor signaling pathway, and complement and coagulation cascades were enriched in CD14 cells. Furthermore, according to GSE152978 and GSE152979, 1939 DEGs were identified in patients with ARDS and controls; they were mainly enriched in the Kyoto Encyclopedia of Genes and Genomes pathways. RBP7 had the highest area under the curve values among the 12 hub genes and was mainly expressed in CD14 cells. Additionally, hub genes were negatively correlated with NK cells and positively correlated with neutrophils, cytotoxic cells, B cells, and macrophages. Conclusion: A severe imbalance in the proportion of immune cells and immune dysfunction were observed in SEP-ARDS and PNE-ARDS patients. RBP7 may be immunologically associated with CD14 cells and serve as a potential marker of ARDS. Keywords: acute respiratory distress syndrome, single-cell RNA sequencing, biomarker, immune disorders, differentially expressed genes Acute respiratory distress syndrome (ARDS) is a heterogeneous clinical syndrome secondary to alveolar damage with multiple causes that is associated with multiple pathophysiological abnormalities. 1–3 ARDS is characterized by endothelial cell dysfunction and local inflammation. The incidence of ARDS in intensive care units is 10.4%, and the global mortality rate is approximately 40%. 4,5 ARDS is induced by endothelial cell dysfunction and local inflammation, and systemic inflammatory immune responses and dysfunction have an important role in ARDS. 6 Important factors associated with the high mortality rate of ARDS are its treatment, which is largely focused on clinical management, and the lack of targeted therapies. 7 Therefore, the identification of diagnostic biomarkers and elucidation of immunomodulatory pathogenesis are of great clinical importance to improving treatment strategies for ARDS. 8 When categorized by frequency, the most common underlying causes of ARDS in the emergency department include sepsis, aspiration, pancreatitis, blood transfusion, pneumonia, trauma, and burns. 9 Sepsis-induced ARDS (SEP-ARDS) and pneumonic ARDS (PNE-ARDS) are often associated with high mortality rates or long-term disability. 10,11 Studies have shown that pulmonary fibrosis is a major cause of poor outcome in patients with SEP-ARDS. 12 Pneumonia is a type of lung infection caused by microbial infection, resulting in the accumulation of exudates in the lung parenchyma that compromise respiratory function. 13 Recently, outbreaks of coronavirus disease (COVID-19) have led to an increase in ARDS and highlighted the challenges associated with this syndrome. -Abstract Truncated-

Acute respiratory distress syndrome after SARS-CoV-2 infection on young adult population: International observational federated study based on electronic health records through the 4CE consortium

Characterisation and outcomes of ARDS secondary to pneumonia in patients with and without SARS-CoV-2: a single-centre experience

Predictors of Mortality for Hospitalized Young Adults Aged Less Than 60 Years Old with Severe COVID-19: a Retrospective Study

SARS-CoV-2 Infection Triggers Profibrotic Macrophage Responses and Lung Fibrosis

Acute Respiratory Distress Syndrome and COVID-19: A Literature Review

Clinical features and progression of acute respiratory distress syndrome in coronavirus disease 2019

Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study

Clinical Characteristics and Progression of 2019 Novel Coronavirus-Infected Patients Concurrent Acute Respiratory Distress Syndrome

A Sequent of Gram-Negative Co-Infectome-Induced Acute Respiratory Distress Syndrome Are Potentially Subtle Aggravators Associated to the SARS-CoV-2 Evolution of Virulence

Prevalence of phenotypes of acute respiratory distress syndrome in critically ill patients with COVID-19: a prospective observational study

Using a targeted metabolomics approach to explore differences in ARDS associated with COVID-19 compared to ARDS caused by H1N1 influenza and bacterial pneumonia

Acute Respiratory Distress Syndrome (ARDS) Caused by the Novel Coronavirus Disease (COVID-19): A Practical Comprehensive Literature Review

Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study

ARDS in solid organ transplant recipients hospitalized for COVID-19 based on the 2023 new definition

Acute respiratory distress syndrome: A review of ARDS across the life course

Comparison of Clinical Features and Outcomes between SARS-CoV-2 and Non-SARS-CoV-2 Respiratory Viruses Associated Acute Respiratory Distress Syndrome: Retrospective Analysis

Influence of socio-economic status on functional recovery after ARDS caused by SARS-CoV-2: the multicentre, observational RECOVIDS study

Incidence and outcomes of acute respiratory distress syndrome in intensive care units of mainland China: a multicentre prospective longitudinal study

Single-Cell RNA Sequencing and Transcriptome Analysis Revealed the Immune Microenvironment and Gene Markers of Acute Respiratory Distress Syndrome

Transpulmonary pressure measurements and lung mechanics in patients with early ARDS and SARS-CoV-2

Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study